Plasminogen/plasmin system is involved in such important processes as thrombosis, inflammation
P
lasminogen is the pro-enzyme of plasmin, the main enzyme of fibrinolysis. However, plasminogen is also able to bind to cell surface and provide many important reactions including proteolytic activity, cell migration and signaling. So, plasminogen can play a certain role in such important biological processes as inflammation, thrombosis and cancer [1, 2] . The circulating form of plasminogen is a 92 kDa single-chain zymogen, composed of 791 amino acids and divided into seven structural domains: N-terminal peptide domain, five kringle domains and C-terminal serine protease domain. Four of five kringle domains (K1, K2, K4 and K5) contain lysine-binding sites (LBS), which mediate plasminogen interaction with fibrin clots and cellsurface receptors. K3-LBS does not bind lysine. It was found that K1-LBS is the only LBS for ligand binding in circulating plasminogen, whereas all other LBS are blocked as they are engaged in intramolecular interactions [3] . Compact form of circulating plasminogen is provided by inter-domain interactions between the N-terminal peptide domain and K5 and between K3 and K4 organized in a spiral-type domain conformation [4] . Cleavage of the N-terminal peptide by plasmin yields a truncated form known as Lys-plasminogen, which is present in an open conformation. Lys-form of plasminogen has some functional peculiarities. It is more readily converted into plasmin [5] . Under physiological conditions Lys-plasminogen is not present in circulating blood [6] . However, on the cell surface Lysplasminogen is the predominant substrate for plasminogen activators [7] . Besides, we have found that Lys-plasminogen but not its Glu-form inhibits the thrombin-and collagen-induced aggregation in the preparation of washed platelets and ADP-induced aggregation in preparations of platelet rich plasma. As it is known, there are many proteins which are exposed on the platelet surface during activation and play an important role in platelet aggregation. Some of these proteins are able to interact with plasminogen [8, 9] . It was shown that 6-aminohexanoic acid abolishes the inhibitory effect of Lys-plasminogen that is compatible with the participation of LBS of експериментальні роботи kringle domains in the inhibitory process [10] . The aim of the present work is to study the role of certain kringle domains of plasminogen molecule in the inhibitory effect of Lys-plasminogen and to determine possible plasminogen-binding proteins on the platelet surface.
materials and methods
Human platelets were isolated from blood of healthy volunteers (n = 9). Citrate-dextrose solution was used as an anticoagulant and platelets were washed as previously described [10] . Human Glu-plasminogen was purified from fresh donor plasma with sodium citrate as an anticoagulant and Lys-plasminogen was isolated from Cohn fraction II-III. Lysine-sepharose chromatography was used in both cases [11] . Mini-plasminogen and plasminogen kringles K1-3 and K4 were obtained according to [12] by elastase hydrolyses of plasminogen. Fragment K5 was obtained by the limited proteolysis of mini-plasminogen with pepsin. K5 isolation was carried out by combination of ion-exchange chromatography on DEAE-sephadex A-25 and gel-chromatography on sephadex G-75 [13, 14] . The obtained plasminogen forms, kringles K1-3, K4 and K5 were homogeneous according to electrophoresis data in PAAG [15] . All preparations of plasminogen had no spontaneous plasmin activity.
The influence of plasminogen fragments (K1-3, K4, K5) on the inhibitory effect of Lys-plasminogen has been studied. Platelet aggregation was measured in an aggregometer (SOLAR AT-02, Belorussia). All assays were performed within 60-180 minutes of platelet collection. The preparation of washed platelets (350,000 cells/µl) was set in aggregometer cuvette, then platelet suspension was preincubated with plasminogen fragments (final concentration 0.12-1.2 µм) for one minute at 37 °с under stirring, then 1.2 µм Lys-plasminogen was added to the reaction mixture. After 3 minute incubation the platelet aggregation was stimulated with thrombin (final concentration 1 NIH unit/ml). The preparation of washed platelets stimulated by thrombin was used as a control. The level of control platelet aggregation (the range from 50 to 70%) was taken as 100% value in the histograms.
Biotinylation of plasminogen and its fragments was carried out as described in [16] . The binding of biotin-labeled Glu-, Lys-, mini-plasminogen (Val 442-Pg) and plasminogen kringles K1-3 and K4 to immobilized actin has been studied according to the following procedure. Microtiter plate wells (Nunc, Denmark) were coated with 100µl of 10 µg/ml actin in PBS overnight at 4 ºC and then washed five times with 0.1 M sodium phosphate buffer (PBS), pH 7.4, containing 0.02% tween-20. Wells were blocked with 2% BSA in PBS for one hour at 37 ºC. Biotinylated Glu-, Lys-, mini-plasminogen and K1-3 or K4 were added to wells. After two hours of incubation at 37 ºC the wells were washed and phosphatase-labeled avidin (100 µl of 0.02 ng/ml avidin in PBS) was added to the wells. After one hour of incubation at 37 ºC the wells were washed and pnitrophenyl phosphate (100 µl of 1 mg/ml in 10% diethanolamine buffer, pH 9.8) was added. The alcaline phosphatase-dependent conversion of the substrate was read at 405 nm after 45 minute incubation (Multiscan EX Thermo, China). Experimental data were statistically analyzed using software MS Excel and Agrometr 2.01.
Human plasma thrombin, porcine pancreas elastase, porcine stomach mucose pepsine and bovine muscle actin were purchased from Sigma (USA).
results and discussion
As shown in Fig.1-3 the inhibitory effect of Lys-plasminogen on thrombin-induced platelet aggregation is observed. In the presence of Lys-plasminogen the level of platelet aggregation is an average of two times lower. We have noticed that all studied plasminogen kringles (K1-3, K4 and K5) abolish the inhibitory effect of Lys-plasminogen on platelet aggregation at concentration 1.2 µM. However, we have observed that K5 is more effective than K1-3 and K4. The plasminogen kringle K5 added to the reaction mixture (washed platelets and 1.2 µM Lys-plasminogen) even at concentration 0.12 µM recovers platelet aggregation to 90%, whereas K1-3 and K4 at this concentration reach only near 60% as compared with control aggregation level ( Fig. 1-3) . Besides, we have observed the tendency of slight stimulation of platelet aggregation in the presence of K5 at concentration 1.2 µм (Fig. 3) .
We have also made an attempt to answer the question concerning affinity of plasminogen forms (Glu-or Lys-plasminogen) and plasminogen fragments (K1-3, K4 or mini-plasminogen, which contains K5 and serine protease domain) for actin. Our results showed that Lys-plasminogen possessed the highest affinity for actin (Fig. 4, a) . Glu-plasminogen and plasminogen fragment K1-3 had similar IC 50 value, 113 and 117 nM, respectively. The binding of Fig. 1 (Fig. 4, B) .
The observed effect of plasminogen kringles on the inhibition of platelet aggregation by Lys-plasminogen lets us conclude that LBS of plasminogen kringles provide the plasminogen binding to the adhesive proteins of platelet surface. There are several candidates for the role of Lys-plasminogen receptors on the surface of activated platelets [17, 18] . These proteins are secreted from α-granules and remain bound to platelet surface. One of them is thrombospondin, its receptor CD47 is highly expressed on platelets [19] . Thrombospondin was proposed to bridge platelets via binding to fibrinogen bound to the platelet integrin αIIbβ3 or by binding directly to this integrin [20] . At the same time some of thrombospondin repeats, TSR1 and TSR2, are considered as the binding sites to plasminogen [8] . Thrombospondin has two binding sites for fibrinogen, one of which (TSR1) coincides with plasminogen binding site. It was suggested that the binding site of plasminogen to thrombospondin is located within the kringle 5 domain [21] . It was interesting to note that Lys-plasminogen binds to thrombospondin to a greater extent than Glu-form. At saturation thrombospondin bound approximately 3 times as much of Lys-plasminogen than Glu-plasminogen. So, we can suggest that in our experiments Lys-plasminogen can probably impede the effective binding of thrombospondin to fibrinogen and, as a result, the platelet aggregation can be less effective (see Fig. 5 ). The peculiarity of kringle 5 which we have shown here is in accordance with this suggestion. On the other hand, actin can also be considered as a possible candidate for plasminogen binding. It is known that actin is exposed on the platelet surface after thrombin-induced secretion [22] . Plasminogen is able to bind actin with high affinity [23] . As we can conclude from the obtained results the leading role in this interaction may belong to plasminogen fragment K1-3.
We cannot also strike off fibrinogen from the list of possible candidates for plasminogen binding. It is known that Glu-plasminogen does not bind to fibrinogen in solution, and Lys-plasminogen under these conditions shows little affinity [24] . As it was found before, fibrinogen adsorbed on the surface undergoes conformational changes and acquires експериментальні роботи
Fig. 4. the binding of biotin-labeled Glu-, Lys-, mini-plasminogen (Val 442-pg) and plasminogen kringles k1-3 and k4 to actin (a), the binding of biotin-labeled Lys-plasminogen to actin (B)
Concentration, nM the properties of fibrin [25] , which possesses good binding abilities to Lys-plasminogen [26] . There is also a possibility of immediate interaction of plasminogen with β2-integrins on the platelet surface. Activated but not resting platelets are able to express β2-integrins [27] and specific interaction between isolated K4 of plasminogen and αMβ2-integrin was identified in case of leucocytes [28] . The obtained data let us suggest that kringle 4 may play a certain role in the interaction of Lys-plasminogen with this integrin on the platelet surface. However, the role of αMβ2 in platelet adhesion or aggregation is still unknown. So, the obtained effects of plasminogen kringles let us conclude that LBS of plasminogen kringles can interact with some adhesive proteins on the surface of activated platelets. This interaction may lead to the disturbance of protein-protein interaction which is the necessary condition for efficient platelet aggregation. від Glu-форми, справляє інгібувальний вплив на агрегацію тромбоцитів, стимульовану аDP, колагеном та тромбіном в препаратах збагаченої тромбоцитами плазми та відмитих тромбоцитів. ми показали, що кринглові домени плазміногену забезпечують взаємодію цієї молекули з по-верхневими протеїнами тромбоцитів. метою роботи було вивчення ролі окремих крингло-вих доменів у виявленні інгібувального впливу Lys-плазміногену на агрегацію тромбоцитів та визначення можливих плазміногензв'язуючих протеїнів на поверхні тромбоцитів. Усі фрагмен-ти плазміногену (K1-3, K4 і K5), що були взяті для дослідження, знімали інгібувальний вплив Lys-плазміногену на агрегацію тромбоцитів. по-казано, що ефект K5 більш виражений порівняно з K1-3 та K4. препарати біотинільованих Lys-плазміногену, Glu-плазміногену та фрагмен-та K1-3 виявляли найбільшу афінність до актину, тоді як зв'язування біотинільованих міні-плазміногену та K4 з актином було незначним. ми припускаємо, що інгібувальний ефект Lys-плазміногену є наслідком взаємодії кринглових доменів цього протеїну з мембранозв'язаними протеїнами, що експонуються на поверхні тром-боцита під час активації та залучаються до про-цесу тромбоутворення. к л ю ч о в і с л о в а: крингли плазміногену, агрегація тромбоцитів, плазміногенові рецепто-ри тромбоцитів, Lys-плазміноген, актин. плазминоген/плазминовая система во-влечена в такие важные процессы как тромбо-образование, воспаление и канцерогенез. плаз-миноген и плазмин опосредуют свое действие через плазминогенсвязывающие протеины на поверхности клеток. Lys-плазминоген, в отли-чие от Glu-формы, оказывает ингибирующее влияние на агрегацию тромбоцитов, стимули-рованную аDP, коллагеном и тромбином в пре-паратах обогащенной тромбоцитами плазмы и отмытых тромбоцитов. мы показали, что крин-гловые домены плазминогена обеспечивают вза-имодействие этого проэнзима с поверхностны-ми протеинами тромбоцитов. Целью настоящей работы было изучить роль определенных крин-гловых доменов в реализации ингибиторного эффекта Lys-плазминогена и определить воз-можные плазминогенсвязывающие протеины на поверхности тромбоцитов. Все исследуемые фрагменты плазминогена (K1-3, K4 и K5) снима-ли ингибирующее действие Lys-плазминогена на агрегацию тромбоцитов. мы обнаружили, что к5 обладал более выраженным эффектом по сравнению с K1-3 и K4. препараты биоти-нилированных протеинов Lys-плазминогена, Glu-плазминогена, и фрагмента K1-3 проявляли наибольшее сродство к актину, в то время как связывание биотинилированных мини-плазми-ногена и K4 с актином было незначительным. мы предполагаем, что ингибиторный эффект Lys-плазминогена является следствием взаимо-действия крингловых доменов этого протеина с мембраносвязанными протеинами, которые экс-понируются на поверхности тромбоцита во вре-мя активации и вовлекаются в процесс тромбо-образования. к л ю ч е в ы е с л о в а: кринглы плазмино-гена, агрегация тромбоцитов, плазминогеновые рецепторы тромбоцитов, Lys-плазминоген, актин. 
